|
Sanchez Soler MJ, Lopez-Gonzalez V, Ballesta-Martinez MJ, Galvez-Pradillo J, Nicolas-Arnao M, Gomez-Sanchez E, Perez-Fernandez V, Guillen Navarro E. Risk of mayor and minor birth defects in children conceived by assisted reproductive technology (IVF/ICSI): A prospective controlled cohort study. An Pediatr (Engl Ed). 2021 Dec;95(6):448-458. doi: 10.1016/j.anpede.2021.06.009. Epub 2021 Nov 29. PubMed PMID: 34857501.
AÑO: 2021
|
34857501
|
Bravo-Gutierrez FJ, Miralles-Lopez JC, Valverde-Molina J, Alemany Frances ML, Andujar-Espinosa R, Castilla-Martinez M, Aviles-Ingles MJ, Mora-Gonzalez A, Pajaron-Fernandez MJ, Cabrejos-Perotti S, Meseguer-Arce J, Flores Martin I, Perez-Fernandez V; RE-ASGRAMUR Group. Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study. Int Arch Allergy Immunol. 2024;185(3):253-259. doi: 10.1159/000534902. Epub 2023 Nov 30. PubMed PMID: 38035559.
AÑO: 2024; IF: 1.8
|
|
Sanchez-Campillo M, Gazquez A, Pastor-Fajardo MT, Lopez-Andreo MJ, Perez-Andres A, Martinez-Gracia C, Vioque J, Perez-Fernandez V, Garcia-Marcos L, Larque E; Nela Study Group. Breastmilk polyamines modify gut gene expression in children at three months of age. Clin Nutr. 2025 Mar;46:80-87. doi: 10.1016/j.clnu.2025.01.025. Epub 2025 Jan 22. PubMed PMID: 39889496.
AÑO: 2025; IF: 7.4
|
|
Miralles-Lopez JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Cabrejos-Perotti S, Ramirez-Hernandez M, Diaz-Chantar C, Pajaron-Fernandez MJ, Valverde-Molina J, Perez-Fernandez V; RE-ASGRAMUR GROUP. Tezepelumab in Patients With Severe Asthma: Response at 3 Months. J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1041. Online ahead of print. No abstract available. PubMed PMID: 39584417.
AÑO: 2024; IF: 4.8
|
|
Miralles-Lopez JC, Cortes Collado JJ, Petryk Petryk Y, Bravo-Gutierrez FJ, Andujar-Espinosa R, Ramirez Hernandez M, Castilla-Martinez M, Diaz-Chantar C, Ibarra-Calabuig I, Valverde-Molina J, Perez-Fernandez V, Group RA. Real-life efficacy of Tezepelumab in patients with failure to other biologic drugs. Eur Ann Allergy Clin Immunol. 2025 Oct 10. doi: 10.23822/EurAnnACI.1764-1489.416. Online ahead of print. No abstract available. PubMed PMID: 41070810.
AÑO: 2025; IF: 2.3
|